{"id":247672,"date":"2022-11-10T12:52:02","date_gmt":"2022-11-10T17:52:02","guid":{"rendered":"http:\/\/boracdmo.com\/?p=247672"},"modified":"2025-03-14T15:18:12","modified_gmt":"2025-03-14T15:18:12","slug":"bora-pharmaceuticals-featured-in-fierce-pharma-boras-quest-to-join-ranks-of-top-cdmos","status":"publish","type":"post","link":"https:\/\/boracdmo.com\/bora-pharmaceuticals-featured-in-fierce-pharma-boras-quest-to-join-ranks-of-top-cdmos\/","title":{"rendered":"Bora Pharmaceuticals Featured in Fierce Pharma – Bora’s Quest to Join Ranks of Top CDMOs"},"content":{"rendered":"\n

 <\/p>\n\n\n\n

Fierce Pharma features a discussion with CEO, Bobby Sheng in an article entitled “After Bora’s biologics debut, CEO outlines quest to join ranks of top CDMOs”.<\/p>\n\n\n\n

Published on November 10, 2022
Thank you Fierce Pharma and author Fraiser Kansteiner<\/p>\n\n\n\n

Bora’s focus on customer partnership is key to Bora’s acquisition strategy. Bora’s recent addition of biologics offerings with acquisition of Eden Biologics is one example.  \u201cBora\u2019s not about recreating the wheel,\u201d Sheng told Fierce Pharma. \u201cBora\u2019s about finding opportunities and providing something for the customer they don\u2019t have yet<\/em>.\u201d<\/p>\n\n\n\n

<\/p>\n\n\n\n

\n
Read the full article<\/a><\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

  Fierce Pharma features a discussion with CEO, Bobby Sheng in an article entitled “After Bora’s biologics debut, CEO outlines quest to join ranks of top CDMOs”. Published on November 10, 2022Thank you Fierce Pharma and author Fraiser Kansteiner Bora’s focus on customer partnership is key to Bora’s acquisition strategy. Bora’s recent addition of biologics […]<\/p>\n","protected":false},"author":2,"featured_media":247684,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[3,4],"tags":[8,9,10,12,15],"class_list":["post-247672","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-events","category-borapressmentions","tag-cdmo","tag-contract-manufacturer","tag-drug-development","tag-manufacturing-expansion","tag-technology-transfer"],"aioseo_notices":[],"acf":[],"_links":{"self":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts\/247672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/comments?post=247672"}],"version-history":[{"count":1,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts\/247672\/revisions"}],"predecessor-version":[{"id":987499133,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/posts\/247672\/revisions\/987499133"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/media\/247684"}],"wp:attachment":[{"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/media?parent=247672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/categories?post=247672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/boracdmo.com\/en\/wp-json\/wp\/v2\/tags?post=247672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}